Option Care(US:OPCH) Globenewswireยท2025-07-30 11:00Core Viewpoint - Option Care Health, Inc. reported strong financial results for the second quarter of 2025, demonstrating resilience in a dynamic marketplace and focusing on delivering strong clinical outcomes while reducing the total cost of care [3][6]. Financial Performance - Net revenue for the second quarter of 2025 was $1,416.1 million, representing a 15.4% increase from $1,227.2 million in the second quarter of 2024 [6]. - Gross profit was $269.0 million, or 19.0% of net revenue, up 7.9% from $249.4 million, or 20.3% of net revenue, in the second quarter of 2024 [6]. - Net income was $50.5 million, compared to $53.0 million in the second quarter of 2024, with diluted earnings per share of $0.31, a 3.3% increase from $0.30 in the same period last year [6]. - Adjusted net income was $67.5 million, up from $64.9 million in the second quarter of 2024, with adjusted diluted earnings per share of $0.41, a 10.8% increase from $0.37 [6][19]. - Adjusted EBITDA reached $114.0 million, a 5.2% increase from $108.4 million in the second quarter of 2024 [6]. Full Year 2025 Financial Guidance - The company expects full year 2025 net revenue to be between $5.50 billion and $5.65 billion, with adjusted diluted earnings per share projected between $1.65 and $1.72 [7]. - Adjusted EBITDA is anticipated to be between $465 million and $475 million, with cash flow from operations expected to be at least $320 million [7]. Operational Insights - The company has over 8,000 team members, including more than 5,000 clinicians, and operates across all 50 states, focusing on elevating standards of care for patients with acute and chronic conditions [4]. - Option Care Health is committed to reimagining the infusion care experience through clinical leadership and expertise [4].